Hydrocortisone

is prescribed to treat:

• Skin inflammation, itching, and rashes • Various related conditions in the dermatology category • Associated symptoms and complications

It is an important medication that helps manage these conditions effectively.

Hydrocortisone is a corticosteroid used topically for inflammatory skin conditions including eczema, dermatitis, and insect bites, and systemically for adrenal insufficiency and acute inflammatory conditions. It is identical to cortisol, the hormone the adrenal cortex produces, which gives it a distinctive role in replacement therapy.

Mechanism of Action

Hydrocortisone binds intracellular glucocorticoid receptors, and the receptor complex moves to the nucleus where it alters gene transcription — suppressing pro-inflammatory cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory mediators. In skin this reduces inflammation, vasodilation, and the itch-scratch cycle that perpetuates eczematous disease.

Because hydrocortisone is chemically identical to endogenous cortisol, it also has mineralocorticoid activity — sodium and water retention with potassium loss — which synthetic corticosteroids such as prednisone have largely engineered out. That property is a disadvantage when high anti-inflammatory potency is wanted, and an advantage in adrenal insufficiency, where both glucocorticoid and mineralocorticoid replacement are needed.

Its short half-life is likewise a drawback for sustained anti-inflammatory use and an advantage in replacement, where the aim is to mimic the natural cortisol rhythm — higher in the morning, falling through the day.

Topically, hydrocortisone is the mildest of the corticosteroid potency classes, which is why it is available over the counter while stronger agents are not.

Topical Potency and Where It Applies

Topical corticosteroids are grouped into potency classes, and matching potency to both the condition and the body site is the central skill in using them.

Skin thickness varies enormously. The face, eyelids, genitals, and skin folds absorb far more drug and are far more prone to atrophy, so only low-potency agents such as hydrocortisone belong there. Palms and soles are thick and poorly penetrated, and hydrocortisone applied to a thick plaque on the sole accomplishes essentially nothing — that requires a high-potency agent.

This is the source of two opposite common errors. The first is using an over-the-counter hydrocortisone cream on a condition that needs a stronger agent, concluding that topical steroids do not work, and persisting for months. The second is using a potent steroid on the face or in flexures, causing skin atrophy, telangiectasia, striae, and perioral dermatitis.

Steroid phobia is also worth naming. Fear of topical corticosteroids leads many patients and parents to under-treat eczema, applying too little for too short a period, which prolongs the disease and leads to more total steroid exposure than a proper course would have required. Used correctly for defined periods at appropriate potency, they are safe and effective. The eczema in the Florida climate article covers management here, and our dermatologic team manages skin disease that is not responding.

The fingertip unit — the amount squeezed from the tube along the length of an adult index fingertip, sufficient for roughly two adult palm areas — gives patients a concrete measure and prevents both under- and over-application.

Systemic Use and Adrenal Insufficiency

In adrenal insufficiency, hydrocortisone is the standard replacement precisely because it is cortisol. Dosing mimics the physiologic rhythm, with the larger portion in the morning.

The critical teaching is sick-day rules. Patients with adrenal insufficiency cannot mount the cortisol surge that illness, injury, or surgery demands, and they must increase their dose — typically doubling or tripling it — during febrile illness, and receive parenteral hydrocortisone if vomiting prevents oral intake.

Failure to do this causes adrenal crisis, which presents with hypotension, vomiting, abdominal pain, confusion, and can be fatal. Every patient on replacement should have an emergency injection kit, know how to use it, have someone else who knows, and carry identification stating they are steroid-dependent. This is not optional education. The MedlinePlus hydrocortisone entry covers prescribing detail, and the NIDDK adrenal insufficiency resource covers sick-day management.

Monitoring and Follow-Up

For topical use, monitoring is clinical: is the condition responding, and is there evidence of atrophy — thinning, shininess, visible vessels, striae — at treated sites? Prolonged continuous use of even a mild steroid on thin skin causes change.

Treatment should be for defined periods with breaks, or on a proactive intermittent schedule for chronic disease, rather than open-ended daily application. Emollients used generously alongside reduce the amount of steroid required substantially and are the foundation of eczema care.

For systemic replacement, monitoring covers weight, blood pressure, electrolytes, and symptoms of over- or under-replacement. There is no reliable biochemical marker of adequate glucocorticoid replacement, so clinical assessment carries the weight.

Special Populations

In children, skin surface area relative to body weight is larger and absorption proportionally greater; low-potency agents and short courses are the rule, and potent steroids under occlusive nappies produce substantial systemic absorption.

In pregnancy, topical corticosteroids are used, with mild to moderate potency preferred and large quantities of potent agents avoided. In older adults, skin is thinner and atrophy occurs more readily.

Patients on long-term systemic steroids for any reason have suppressed adrenal function and face the same crisis risk during illness — a fact that applies well beyond diagnosed adrenal insufficiency and is frequently overlooked.

One diagnostic caution applies to any topical steroid. Applied to a fungal infection, a corticosteroid suppresses the inflammation without touching the organism, so the rash looks better briefly, then spreads with an altered, less recognisable appearance. This is common on the feet, groin, and body, and it is why a rash that improves then worsens on hydrocortisone should be reconsidered rather than treated harder.

When to Contact Your Doctor

For adrenal insufficiency, seek emergency care for vomiting, severe weakness, dizziness, confusion, or abdominal pain, and use your emergency injection — this is adrenal crisis. Contact us at the start of any febrile illness for dose adjustment rather than waiting.

For topical use, report a rash that is not improving after an appropriate course, worsening or spreading redness, or signs of infection. Report skin thinning, stretch marks, or visible vessels at treated sites.

Report a rash on the face or in skin folds before treating it with anything stronger than hydrocortisone.

To review skin treatment that is not working, adjust steroid replacement, or discuss sick-day rules, contact us or schedule a visit.